LUMUS Investment Collective

Kardi AI is a developer of an innovative heart monitoring device that provides medical-grade cardiac home monitoring through the use of artificial intelligence. The company offers a low-cost wearable chest belt that, in conjunction with a smartphone, enables users to monitor and diagnose their heart conditions anytime and anywhere. This device delivers EKG-level performance, allowing patients to receive daily assessments of their heart health. By facilitating seamless communication with cardiologists, Kardi AI aims to expedite the diagnosis process, thereby enhancing the quality of heart care from the comfort of home. The Kardi AI kit is accessible through healthcare providers, ensuring that patients have the necessary tools for effective cardiac monitoring and timely medical intervention if needed.

Founded in 2021, we address the needs of medical professionals with HW and SW solutions that aim to simply and effectively solve the problem at hand without forcing any new systems and workflows onto already overcomplicated hospitals and medical centers. Our main product focuses on automating urine output monitoring, the last vital ICU patient metric that is still measured manually.

Macromo provides AI-driven personalized health insights, online consultations, and recurring at-home tests, all in a unified experience inside a mobile app.